ProCE Banner Activity

Mycophenolate Pregnancy Risks: Patient Information (in French)

PDF

Download this evidence-based educational handout to provide your patients with key information on mycophenolate-associated risks, important steps to prevent pregnancy with acceptable contraception options, what to do if a pregnancy occurs, how to report a pregnancy to the Mycophenolate Pregnancy Registry, and how to start family planning when taking mycophenolate.

Update as of January 2024: There are now 2 systems for healthcare professionals and patients to access educational resources about mycophenolate and report a pregnancy, including the Mycophenolate Shared System REMS and the Parallel System Mycophenolate SS REMS.

Released: November 30, 2023

Share

Faculty

Cara D. Dolin

Cara D. Dolin, MD, MPH

Assistant Professor of Obstetrics/Gynecology and Reproductive Biology
Division of Maternal-Fetal Medicine
Obstetrics and Gynecology Institute
Cleveland Clinic Lener College of Medicine
Case Western Reserve University School of Medicine
Cleveland, Ohio

Diana Girnita

Diana Girnita, MD, PhD

Scientific and Medical Consultant
Assistant Prof Rheumatology (Volunteer)
University Of Cincinnati
CEO & Founder Rheumatologist OnCall
Irvine, California

Provided by

Provided by Boston University Chobanian & Avedisian School of Medicine, in partnership with Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported by an independent educational grant from the Mycophenolate REMS Group. This activity is intended to be fully compliant with the Mycophenolate REMS education requirements issued by the U.S. Food and Drug Administration (FDA).

Mycophenolate REMS Group

Partners

Clinical Care Options, LLC

ProCE Banner

Disclosure

Primary Author

Cara D. Dolin, MD, MPH

Assistant Professor of Obstetrics/Gynecology and Reproductive Biology
Division of Maternal-Fetal Medicine
Obstetrics and Gynecology Institute
Cleveland Clinic Lener College of Medicine
Case Western Reserve University School of Medicine
Cleveland, Ohio

Cara D. Dolin, MD, MPH, has no relevant financial relationships to disclose.

Diana Girnita, MD, PhD

Scientific and Medical Consultant
Assistant Prof Rheumatology (Volunteer)
University Of Cincinnati
CEO & Founder Rheumatologist OnCall
Irvine, California

Diana Girnita, MD, PhD: consultant/advisor/speaker: Sigma MD; owner: Rheumatologist OnCall.